Parimifasor

Overview

Parimifasor (LYC-30937) is an orally active agent for inflammatory bowel disease. Parimifasor targets F1F0-ATPase . Parimifasor acts on respiratory complex V, slows ATP production and induces Apoptosis . Parimifasor can be used in the research of inflammatory bowel disease.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > ATP Synthase | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-109098
• CAS No.: 1796641-10-5
• Molecular Formula: C18H11Cl2F4N5O
• Molecular Weight: 460.21
• Purity: 98.53%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: 2.5 mg/mL (5.43 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source